We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

120 hedge funds and large institutions have $267M invested in Arena Pharmaceuticals Inc in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 36 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $3.16M | Put options by funds: $1.97M

17% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 36

8% less funds holding

Funds holding: 130 → 120 (-10)

38% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 21

59% less capital invested

Capital invested by funds: $648M → $267M (-$382M)

Holders
120
Holders Change
-10
Holders Change %
-7.69%
% of All Funds
3.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
42
Reduced
36
Closed
21
Calls
$3.16M
Puts
$1.97M
Net Calls
+$1.2M
Net Calls Change
-$1.73M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$9.11M
2
CCM
Camber Capital Management
Massachusetts
+$7.64M
3
SAM
Senzar Asset Management
New York
+$6M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.17M
5
Citadel Advisors
Citadel Advisors
Florida
+$2.54M

Top Sellers

Rank Fund Capital Flow
1
O
OppenheimerFunds
New York
-$32.5M
2
DM
Deerfield Management
New York
-$7.96M
3
OAM
Oxford Asset Management
United Kingdom
-$2.39M
4
CCMH
Cornerstone Capital Management Holdings
New York
-$1.28M
5
CC
Callan Capital
California
-$1.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
126
Murphy Capital Management
New Jersey
– -$106K -2,300 Closed
GC
127
Guggenheim Capital
Illinois
– -$97K -2,095 Closed
PPA
128
Parametric Portfolio Associates
Washington
– -$87K -1,876 Closed
Nomura Holdings
129
Nomura Holdings
Japan
– -$73K -1,525 Closed
QC
130
QCM Cayman
Texas
– -$69K -1,484 Closed
Verition Fund Management
131
Verition Fund Management
Connecticut
– -$64K -1,382 Closed
M&T Bank
132
M&T Bank
New York
– -$57K -1,232 Closed
VF
133
Virtu Financial
New York
– -$54K -1,156 Closed
PAM
134
Princeton Alpha Management
New Jersey
– -$52K -1,111 Closed
Walleye Trading
135
Walleye Trading
New York
– -$8K -170 Closed
Fifth Third Bancorp
136
Fifth Third Bancorp
Ohio
– -$7K -150 Closed
BJ
137
BlackRock Japan
Japan
– -$4K -82 Closed
BRWM
138
B. Riley Wealth Management
Tennessee
– -$1K -40 Closed
MFS
139
MSI Financial Services
Massachusetts
– -$1K -14 Closed
GT
140
Glenmede Trust
Pennsylvania
– +$611 +18 New
2 3 4 5
6

ARNA Hedge Fund Activity: Q3 2015 in Review

120 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2015, worth a combined $267M — down 59% from $648M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ARNA and 13 opened new positions — a net loss of 8 holders — while 36 trimmed existing stakes and 42 added.

The largest buyer was State Street, adding an estimated $9.11M. The largest seller was OppenheimerFunds, exiting entirely with an estimated $32.5M sold.

  • 120 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2015, down from 130 in Q2 2015.
  • Funds reported $267M of Arena Pharmaceuticals Inc stock for Q3 2015, down 59% quarter-over-quarter.
  • 13 funds opened new Arena Pharmaceuticals Inc positions in Q3 2015 and 21 closed out, a net change of -8 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q3 2015 was State Street, an estimated $9.11M added.
  • The largest Arena Pharmaceuticals Inc seller in Q3 2015 was OppenheimerFunds, an estimated $32.5M sold.

Based on aggregated 13F filings for Q3 2015.